High-level levofloxacin-resistant emm12 group A Streptococcus, 2012-2018: A multicenter study in Taiwan.

Authors :: Huang YC
Lai JF
Wu CJ
Huang IW
Kuo SC
Liao CL
Huang TW
Lauderdale TL
Source :: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2023 Aug; Vol. 56 (4), pp. 875-879. Date of Electronic Publication: 2023 May 06.
Publication Year :: 2023
Abstract: High-level levofloxacin-resistant group A Streptococcus emerged in Taiwan in 2012. Among the 24 isolates identified, 23 belonged to emm12/ST36, most harbored the same GyrA and ParC mutations and were highly clonal. wgMLST showed them to be closely related to the Hong Kong scarlet fever outbreak strains. Continuous surveillance is warranted.<br /> (Copyright © 2023. Published by Elsevier B.V.)

Subjects :: Humans
Levofloxacin pharmacology
Taiwan epidemiology
Streptococcus pyogenes
Hong Kong
Microbial Sensitivity Tests
Anti-Bacterial Agents pharmacology
Anti-Bacterial Agents therapeutic use
Drug Resistance, Bacterial genetics
Scarlet Fever drug therapy
Scarlet Fever epidemiology
Streptococcal Infections epidemiology
Streptococcal Infections drug therapy

Language :: English
ISSN :: 1995-9133
Volume :: 56
Issue :: 4
Database :: MEDLINE
Journal :: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Publication Type :: Academic Journal
Accession number :: 37188572
Full Text :: https://doi.org/10.1016/j.jmii.2023.04.010

Full Text Access

Tools